American Lung Association News - Protect Yourself Against More Than The Sun This Summer

Health and Fitness

August 8, 2023

Protect Your Lung Health

Celebrate National Immunization Awareness Month this August and safeguard yourself beyond the sun this summer. Even though chronic lung disease increases your risk for infectious respiratory illness, these facts and resources can help ensure your protection.

1 Pneumococcal Pneumonia??

Adults aged 19-49 with chronic lung disease are at 19.1x greater risk for pneumococcal pneumonia versus healthy adults aged 18-49. Pneumococcal pneumonia can strike anytime — even in the summer months and pneumococcal pneumonia vaccines are available year-round to help prevent this potentially serious disease. Talk to your healthcare provider about pneumococcal vaccination.

Learn more

The American Lung Association and Pfizer are partnering to share important facts about pneumococcal pneumonia.?


In June 2023, the CDC recommended respiratory syncytial virus (RSV) vaccination for adults 60 or older. There are currently two licensed RSV vaccines for adults 60+ and they are expected to become available in the fall of 2023. Discuss with your healthcare provider if RSV vaccination is right for you.??

Learn more

3 Vaccines Without Cost

Thanks to the Inflation Reduction Act, Medicare Part B and Part D now cover all CDC recommended vaccines without cost. And beginning in October 2023, Medicaid coverage will be required to include these vaccines too.

This includes vaccines to help protect against infectious respiratory diseases like:

Pneumococcal pneumonia, COVID-19, Influenza, pertussis and RSV.

Learn more

Top Resources for You

- Understand infectious respiratory disease in our free, self-paced online course.
- Check out vaccination information that will help protect your lungs.
- Call the Lung HelpLine to talk with an expert about your lung-health related questions.

Meet A Researcher

Streptococcus pneumoniae remains a cause of infectious disease deaths worldwide, with nearly one million fatalities annually. To combat this, Jarrod Mousa, PhD and his team are developing human monoclonal antibodies as an alternative treatment to prevent severe pneumococcal disease.

Meet Dr. Jarrod